AI & Machine Learning in Biotechnology
Eli Lilly’s deal man, Allogene’s off-the-shelf CAR-T, and Merck’s Terns buy
On this week’s episode of “The Readout LOUD”: Allison DeAngelis is still away, leaving Elaine Chen and Adam Feuerstein to mind the podcasting store. You’ve been warned.
Eli Lilly’s deal man Jake van Naarden is very, very busy, so what does that mean for biotech and pharma? Speaking of deals, Merck is buying Terns for nearly $7 billion. Why are some people mad about it?
On this week’s episode of “The Readout LOUD”: Allison DeAngelis is still away, leaving Elaine Chen and Adam Feuerstein to mind the podcasting store. You’ve been warned.
Eli Lilly’s deal man Jake van Naarden is very, very busy, so what does that mean for biotech and pharma? Speaking of deals, Merck is buying Terns for nearly $7 billion. Why are some people mad about it?